The blog post on the Imperial Medicine Blog highlights pioneering research into psychedelics by the Imperial Centre for Psychedelic Research, led by Professor David Nutt. It explores the potential of psilocybin and other psychedelics in the treatment of mental health disorders, making breakthroughs where traditional treatments fell short. With a focus on mechanisms of action, the research shows promise for conditions such as depression, OCD and chronic pain. This pioneering work redefines our approach to mental health care, emphasising the need for innovative treatments. For a detailed reading, visit the full blog post here.
Selecteer een pagina